MyRNK wins on Sermorelin price, health coach inclusion, and fast delivery. Limitless Alt Med wins on peptide access — BPC-157, PT-141, TRT, and GHK-Cu alongside free consultations and published pricing.
| MyRNK | Limitless Alt Med | |
|---|---|---|
| Sermorelin | $129/mo (no labs) | $194 |
| NAD+ | $129/mo | $180/vial |
| BPC-157 | Not offered | Injectable $325 |
| PT-141 | Not offered | $184 |
| GHK-Cu | Not offered | Yes — blends available |
| Enclomiphene | $189/mo | TRT $115–$170/mo |
| GLP-1 (Sema/Tirze) | Sema $197, Tirze $297 | Sema sublingual $200, Tirze $275–$400 |
| Labs Required? | No ($0) | 95% of treatments without bloodwork |
| Health Coach | Included free | — |
| Consultation Fee | Included in sub | Free |
| Delivery | 48-hr, all 50 states | Standard |
| Full Review | Read MyRNK Review → | Read Limitless Review → |
MyRNK's formulary covers the most popular protocols: NAD+ ($129/mo), Sermorelin ($129/mo), Enclomiphene ($189/mo), Semaglutide ($197/mo), and Tirzepatide ($297/mo). No labs required. Health coach included. 48-hour delivery anywhere in the US. For most patients, this covers everything needed.
Limitless Alt Med adds BPC-157 ($325), PT-141 ($184), GHK-Cu blends, and TRT ($115–$170/mo) — compounds that MyRNK does not offer. Their Sermorelin at $194 is more expensive than MyRNK's $129/month subscription, and NAD+ at $180/vial is higher than MyRNK's monthly rate. But for patients who specifically want BPC-157, PT-141, or GHK-Cu blends, Limitless is currently the better option.
Sermorelin $129/mo (no labs), NAD+ $129/mo, Enclomiphene $189/mo. Health coach included. 48-hr delivery. Flat pricing with 24,000+ Trustpilot reviews.
BPC-157 $325, PT-141 $184, GHK-Cu blends, Sermorelin $194, NAD+ $180/vial, TRT $115–$170/mo. Free consults. Published per-compound pricing.
MyRNK wins for ongoing Sermorelin therapy — $129/month with no lab requirement, included health coach, and fast delivery is a better ongoing value than Limitless Alt Med's $194 Sermorelin. For NAD+, MyRNK's $129/month rate also beats Limitless's $180/vial price.
Limitless Alt Med wins if BPC-157, PT-141, GHK-Cu, or TRT are part of your protocol. Their published pricing for every compound, free consultations, and peptide access without mandatory bloodwork make them the better clinic for patients who want peptide-first therapy.
Yes — BPC-157 injectable at $325. Limitless also offers PT-141 ($184), GHK-Cu blends, Sermorelin ($194), and NAD+ ($180/vial). MyRNK does not offer BPC-157, PT-141, or GHK-Cu.
Yes for ongoing use. MyRNK's Sermorelin is $129/month with no lab requirement. Limitless Alt Med prices Sermorelin at $194 (not a monthly subscription rate). MyRNK is the better ongoing value for Sermorelin therapy.
Yes — a health coach is included free with the MyRNK subscription. Limitless Alt Med offers free consultations but does not include an ongoing health coach as part of the service.